But what can it successfully treat? What is ivermectin? The drug is a small organic chemical that can be extracted from the ...
Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the “immune imprinting” issue that has contributed to the declining effectiveness of boosters as the virus mutates.
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) announced completion of a 90-patient Phase 2 study evaluating its ...
Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds with equivalent time to sustained symptom resolution; ...
SAN FRANCISCO (KGO) -- The popular COVID treatment, Paxlovid, does not significantly lower the risk of "long COVID" for people who are vaccinated. In a new study from UCSF, researchers found that ...
RAHWAY, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the Phase 3 MOVe-NOW clinical trial to evaluate ...
A COVID-19 risk calculator developed by a group of universities in Australia can now also determine a person's risk of developing long COVID. The obstinate condition, which reportedly affects at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results